398 reports of this reaction
0.8% of all TAPENTADOL HYDROCHLORIDE reports
#14 most reported adverse reaction
INTENTIONAL PRODUCT MISUSE is the #14 most commonly reported adverse reaction for TAPENTADOL HYDROCHLORIDE, manufactured by Collegium Pharmaceutical, Inc.. There are 398 FDA adverse event reports linking TAPENTADOL HYDROCHLORIDE to INTENTIONAL PRODUCT MISUSE. This represents approximately 0.8% of all 50,606 adverse event reports for this drug.
TAPENTADOL HYDROCHLORIDE has an overall safety score of 92 out of 100. Patients taking TAPENTADOL HYDROCHLORIDE who experience intentional product misuse should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
INTENTIONAL PRODUCT MISUSE is a less commonly reported adverse event for TAPENTADOL HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to intentional product misuse, the following adverse reactions have been reported for TAPENTADOL HYDROCHLORIDE:
The following drugs have also been linked to intentional product misuse in FDA adverse event reports:
INTENTIONAL PRODUCT MISUSE has been reported as an adverse event in 398 FDA reports for TAPENTADOL HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
INTENTIONAL PRODUCT MISUSE accounts for approximately 0.8% of all adverse event reports for TAPENTADOL HYDROCHLORIDE, making it a notable side effect.
If you experience intentional product misuse while taking TAPENTADOL HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.